Zobrazeno 1 - 10 of 211 pro vyhledávání: '"M. J., Van Den Bent"'
1
Elektronická kniha
Metastatic Disease of the Nervous System
Autor: David Schiff, M J Van den Bent
Metastatic Disease of the Nervous System, Volume 149, begins with an overview of the impact and range of direct neoplastic involvement of the central and peripheral nervous system, comprehensively reviewing all aspects of brain metastases, from clini
Zobrazit plný text záznamu
2
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol
Autor: L. Bleeker, M. C. M. Kouwenhoven, I. de Heer, B. I. Lissenberg-Witte, A. H. Gijsbers, H. J. Dubbink, J. M. Kros, J. M. M. Gijtenbeek, E. Kurt, C. C. D. van der Rijt, A. T. Swaak-Kragten, F. Y. de Vos, H. L. van der Weide, P. J. French, M. J. van den Bent, P. Wesseling, J. E. C. Bromberg
Publikováno v: Journal of Neuro-Oncology, 162, 1, pp. 225-235
Journal of Neuro-Oncology, 162, 225-235
JOURNAL OF NEURO-ONCOLOGY, 162. SPRINGER
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic
Journal of Neuro-Oncology, 162(1), 225-235. Kluwer Academic Publishers
Bleeker, L, Kouwenhoven, M C M, de Heer, I, Lissenberg-Witte, B I, Gijsbers, A H, Dubbink, H J, Kros, J M, Gijtenbeek, J M M, Kurt, E, van der Rijt, C C D, Swaak-Kragten, A T, de Vos, F Y, van der Weide, H L, French, P J, van den Bent, M J, Wesseling, P & Bromberg, J E C 2023, ' Medulloblastoma in adults : evaluation of the Dutch society for neuro-oncology treatment protocol ', Journal of Neuro-Oncology, vol. 162, no. 1, pp. 225-235 . https://doi.org/10.1007/s11060-023-04285-8
Purpose Medulloblastoma is a rare tumor in adults. The objective of this nationwide, multicenter study was to evaluate the toxicity and efficacy of the Dutch treatment protocol for adult medulloblastoma patients. Methods Adult medulloblastoma patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67427e41dff228838387fb83cfe695a8
Zobrazit plný text záznamu
3
P09.06.B The effectiveness of antiepileptic drug tripletherapy in refractory epileptic glioma patients
Autor: P B van der Meer, L Dirven, M Fiocco, M J Vos, M C M Kouwenhoven, M J van den Bent, M J B Taphoorn, J A F Koekkoek
Background About 10% of the glioma patients need antiepileptic drug (AED) tripletherapy due to refractory epilepsy. This study aimed to determine whether levetiracetam combined with valproic acid and clobazam (LEV+VPA+CLB), a commonly prescribed trip
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ce6a76e2061453ce6f10e30d09971
https://hdl.handle.net/1887/3503886
Zobrazit plný text záznamu
5
OS03.6.A Rituximab in primary CNS lymphoma - long term follow-up of the phase III HOVON 105/ALLG NHL 24 Study
Autor: J E C Bromberg, S Issa, B van der Holt, M C Minnema, T Seute, M F Durian, G Cull, M W M van der Poel, W B C Stevens, J M Zijlstra, M Nijland, K D Mason, A Beeker, D Brandsma, M J van den Bent, M Gonzalez, D de Jong, J K Doorduijn
Publikováno v: Neuro-Oncology. 24:ii12-ii13
Background The efficacy of rituximab in Primary CNS Lymphoma (PCNSL) is still under debate. We performed an international randomized phase III study to investigate the efficacy of rituximab when added to methotrexate, BCNU, teniposide and prednisolon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd3fbd3e5b73137ec98a5725761fddcc
https://doi.org/10.1093/neuonc/noac174.038
Zobrazit plný text záznamu
6
Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study
Autor: J.K. Doorduijn, Gavin Cull, Kylie D. Mason, Monique C. Minnema, M. J. van den Bent, Katerina Bakunina, Martin J B Taphoorn, Samar Issa, Wendy Stevens, Max Beijert, Marcel Nijland, Jacoline E C Bromberg, Aart Beeker, Joke W. Baars, Linda Dirven, M. van der Meulen
Publikováno v: Annals of Oncology, 31(8), 1046-1055. Elsevier Ltd.
Annals of Oncology, 31, 8, pp. 1046-1055
Annals of Oncology, 31(8), 1046-1055. Oxford University Press
Annals of Oncology, 31, 1046-1055
Annals of Oncology, 31(8), 1046-1055. ELSEVIER
Background: The impact of rituximab on health-related quality of life (HRQoL) in primary central nervous system lymphoma patients is not well known. We determined the impact of rituximab added to standard high-dose methotrexate-based treatment on HRQ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca094d9259d25211d496baaaa8801575
https://pure.eur.nl/en/publications/f481ab99-6beb-4bbf-a8d7-bef54ac0ba41
Zobrazit plný text záznamu
7
OS09.6.A Cognition and health-related quality of life in long time survivors of high-grade glioma
Autor: Djaina Satoer, P A E Sillevis Smit, M Donders-Kamphuis, W S Veenstra, Jochem K H Spoor, Sieger Leenstra, S A van Dijk, M. J. van den Bent, C M F Dirven
Publikováno v: Neuro Oncol
BACKGROUND Although prognosis is poor in high-grade glioma (HGG) patients, some become a long-term survivor (LTS). Health-related quality of life (HRQOL) and cognition are seen as indicators for quality of survival in HGG but data in LTS and their ca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6321001a48f22b8195aa18a02e7aaa5e
https://europepmc.org/articles/PMC8427410/
Zobrazit plný text záznamu
8
P12.01 The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
Autor: Johan A F Koekkoek, Mathilde C.M. Kouwenhoven, P B van der Meer, M P van Opijnen, M. J. van den Bent, Linda Dirven, Martin J B Taphoorn, Marta Fiocco
Publikováno v: Neuro Oncol
BACKGROUND Optimal treatment with antiepileptic drugs (AEDs) is an important part of care for brain tumor patients with epileptic seizures. Lamotrigine and lacosamide are both examples of frequently used non-enzyme inducing AEDs with limited to no dr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6491d19594aef6bf894a3901a0ce2251
https://europepmc.org/articles/PMC8427326/
Zobrazit plný text záznamu
9
OS05.5.A Methylation analysis of matched primary and recurrent IDHmt astrocytoma; an update from the Glioma Longitudinal Analysis NL (GLASS-NL) consortium
Autor: J. M. Niers, M. A. van de Wiel, Johan M. Kros, M. C. M. Kouwenhoven, H. F. van Thuijl, Wies Vallentgoed, Pim J. French, Pieter Wesseling, I. Martin, M. J. van den Bent
Publikováno v: Neuro Oncol
BACKGROUND The evolutionary processes that drive progression in patients with IDH-mutant astrocytoma remain unclear. The GLASS-NL consortium, as part of the larger worldwide GLASS consortium, was initiated to gain insight into the molecular mechanism
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3bf027ace174fccc4c3ac5d8d6f417
https://europepmc.org/articles/PMC8427387/
Zobrazit plný text záznamu
10
P07.11.A Impact of awake craniotomy on extent-of-resection and performance in glioma: a retrospective, propensity-score matched cohort study
Autor: S J P Schnitzler, T van der Vaart, K van Garderen, M J van den Bent, A J P E Vincent
Publikováno v: Neuro-Oncology. 24:ii42-ii42
Background The goal of awake craniotomy is to safely optimize the extent-of-resection in patients with glioma. Lower postoperative tumor volume is associated with better overall survival, emphasizing the importance of optimal surgical resection. Awak
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47646c8cbd54218c77654d8ad8c2d308
https://doi.org/10.1093/neuonc/noac174.143
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje